Erlotinib Completed Phase 1 Trials for Breast Cancer Treatment
| Indications | Status | Purpose | Phase |
|---|---|---|---|
| Completed | Treatment | 1 |
| clinicaltrials.gov Identifier | Title | Drugs |
|---|---|---|
| NCT01650506 | Study of Erlotinib and Metformin in Triple Negative Breast Cancer | |
| NCT00574366 | Erlotinib and Everolimus in Treating Patients With Metastatic Breast Cancer |